Addressing insurance-related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery.
Addressing insurance-related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery.
复制标题
DOI：
10.1002/oby.23556
复制
发表时间：
2022-12
期刊：
影响因子：
6.9
通讯作者：
Sarwer, David B.
中科院分区：
文献类型：
--
作者：
Gasoyan, Hamlet;Sarwer, David B.
在过去的十年里，新的抗肥胖药物的发展取得了重大进展，其中一些药物的疗效比美国食品和药物管理局（FDA）先前批准的药物更有效。尽管新药物有可能对抗美国的肥胖危机，但获得这些药物的途径严重受限。本文介绍了目前抗肥胖药物的覆盖情况，包括美国联邦雇员健康福利计划的人事管理办公室最近要求为fda批准的抗肥胖药物提供足够的覆盖，这与扩大减肥手术的保险覆盖范围的条件相似。并强调立法机构和医疗保险和医疗补助服务中心需要采取额外行动，扩大循证肥胖治疗的覆盖范围。
The past decade has witnessed significant progress in the development of new anti-obesity medications, with several having greater efficacy than pharmacological agents previously approved by the Food and Drug Administration (FDA). Despite the potential of new medications to combat America’s obesity crisis, access to these agents is severely limited. This paper presents the current coverage landscape for anti-obesity medications, including the recent requirement by the U.S. Office of Personnel Management for Federal Employees Health Benefits Program carriers to offer adequate coverage of FDA-approved anti-obesity medications, makes parallels with conditions that made expanded insurance coverage for bariatric surgery possible, as well as emphasizes the need for additional action by the legislature and the Centers for Medicare and Medicaid Services to expand coverage of evidence-based obesity treatments.
登录
查看更多内容
影响因子：
2.9
作者：
Gebran, Selim G.;Knighton, Brooks;Rasko, Yvonne M.
通讯作者：
Rasko, Yvonne M.
DOI：
10.1016/j.soard.2021.01.024
发表时间：
2021-05
期刊：
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
影响因子：
--
作者：
Gasoyan H;Ibrahim JK;Aaronson WE;Sarwer DB
通讯作者：
Sarwer DB
影响因子：
3
作者：
Gasoyan H;Soans R;Ibrahim JK;Aaronson WE;Sarwer DB
通讯作者：
Sarwer DB
DOI：
10.1038/s41573-021-00337-8
发表时间：
2022-03
期刊：
Nature reviews. Drug discovery
影响因子：
--
作者：
Müller TD;Blüher M;Tschöp MH;DiMarchi RD
通讯作者：
DiMarchi RD
影响因子：
158.5
作者：
Wilding, John P. H.;Batterham, Rachel L.;Kushner, Robert F.
通讯作者：
Kushner, Robert F.